4.7 Article

Microstructural imaging and transcriptomics of the basal forebrain in first-episode psychosis

Journal

TRANSLATIONAL PSYCHIATRY
Volume 12, Issue 1, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/s41398-022-02136-0

Keywords

-

Categories

Funding

  1. CIHR Foundation [FDN 154296]
  2. Schulich School of Medicine Clinical Investigator Fellowship
  3. Bucke Family Fund
  4. Canada Graduate Scholarship
  5. Chrysalis Foundation
  6. Canada First Excellence Research Fund
  7. Western University
  8. Fonds de recherche du Quebec-Sante (FRQS, 2022)
  9. Graham Boeckh Foundation (Douglas Research Centre, McGill University)
  10. AMOSO Opportunities fund
  11. Monique H. Bourgeois Chair in Developmental Disorders

Ask authors/readers for more resources

Cholinergic dysfunction has been implicated in mental disorders such as schizophrenia and depression. Research found abnormalities in the microstructural neuroimaging measures of the cholinergic nuclei in untreated psychosis patients, indicating a potential link between cholinergic dysfunction and the pathophysiology of mental disorders.
Cholinergic dysfunction has been implicated in the pathophysiology of psychosis and psychiatric disorders such as schizophrenia, depression, and bipolar disorder. The basal forebrain (BF) cholinergic nuclei, defined as cholinergic cell groups Ch1-3 and Ch4 (Nucleus Basalis of Meynert; NBM), provide extensive cholinergic projections to the rest of the brain. Here, we examined microstructural neuroimaging measures of the cholinergic nuclei in patients with untreated psychosis (similar to 31 weeks of psychosis, <2 defined daily dose of antipsychotics) and used magnetic resonance spectroscopy (MRS) and transcriptomic data to support our findings. We used a cytoarchitectonic atlas of the BF to map the nuclei and obtained measures of myelin (quantitative T1, or qT1 as myelin surrogate) and microstructure (axial diffusion; AxD). In a clinical sample (n = 85; 29 healthy controls, 56 first-episode psychosis), we found significant correlations between qT1 of Ch1-3, left NBM and MRS-based dorsal anterior cingulate choline in healthy controls while this relationship was disrupted in FEP (p > 0.05). Case-control differences in qT1 and AxD were observed in the Ch1-3, with increased qT1 (reflecting reduced myelin content) and AxD (reflecting reduced axonal integrity). We found clinical correlates between left NBM qT1 with manic symptom severity, and AxD with negative symptom burden in FEP. Intracortical and subcortical myelin maps were derived and correlated with BF myelin. BF-cortical and BF-subcortical myelin correlations demonstrate known projection patterns from the BF. Using data from the Allen Human Brain Atlas, cholinergic nuclei showed significant enrichment for schizophrenia and depression-related genes. Cell-type specific enrichment indicated enrichment for cholinergic neuron markers as expected. Further relating the neuroimaging correlations to transcriptomics demonstrated links with cholinergic receptor genes and cell type markers of oligodendrocytes and cholinergic neurons, providing biological validity to the measures. These results provide genetic, neuroimaging, and clinical evidence for cholinergic dysfunction in schizophrenia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available